The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | B | Blood and blood forming organs | |
2 | B05 | Blood substitutes and perfusion solutions | |
3 | B05A | Blood and related products | |
4 | B05AA | Blood substitutes and plasma protein fractions |
Code | Title | |
---|---|---|
B05AA01 | Albumin | |
B05AA02 | Other plasma protein fractions | |
B05AA03 | Fluorocarbon blood substitutes | |
B05AA05 | Dextran | |
B05AA06 | Gelatin agents | |
B05AA07 | Hydroxyethylstarch | |
B05AA08 | Hemoglobin crosfumaril | |
B05AA09 | Hemoglobin raffimer | |
B05AA10 | Hemoglobin glutamer (bovine) |
Active Ingredient | Description | |
---|---|---|
Albumin |
Human albumin accounts quantitatively for more than half of the total protein in the plasma and represents about 10% of the protein synthesis activity of the liver. The most important physiological functions of albumin results from its contribution to oncotic pressure of the blood and transport function. Albumin stabilises circulating blood volume and is a carrier of hormones, enzymes, medicinal products and toxins. |
|
Dextran |
|
|
Gelatin |
Gelatin is a colloidal plasma substitute. When used in the treatment of hypovolaemia gelatin produces significant increases in blood volume, cardiac output, stroke volume, blood pressure, urinary output and oxygen delivery. Gelatin promotes osmotic diuresis, thereby helping to protect the kidneys from the adverse effects of hypovolaemia. |
|
Hemoglobin glutamer |
|
|
Human plasma protein fraction |
|
|
HAES |
|
|
Polygeline |
|
Title | Information Source | Document Type | |
---|---|---|---|
ALBUMAN Solution for infusion | Marketing Authorisation Holder | MPI, EU: SmPC | |
ALBUNORM Solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
ALBUREX 20, 200g/l Solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
ALBUREX 5, 50 g/l Solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
ALBURX Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
ALBUTEIN Solution for infusion | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
OCTALBIN Solution for infusion | Health Products and Food Branch (CA) | MPI, CA: SPM | |
OCTAPLAS Solution for infusion | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
OCTAPLASLG Solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
OCTAPLASMA Solution for infusion | Health Products and Food Branch (CA) | MPI, CA: SPM | |
PLASMANATE Solution for infusion | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
VOLPLEX Solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |